United Lincolnshire Hospitals Nhs Trust

This study is testing whether adding a new drug called bomedemstat to an existing drug (momelotinib) can better control myelofibrosis, a serious bone marrow disease. It is for patients who have not had an optimal response to momelotinib alone. About 40 participants will take mome…